1-4 of 4
Andrew T Gewirtz, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Flagellin, a TLR5 Agonist, Reduces GvHD in Allogeneic HSCT Recipients While Enhancing Anti-Viral Immunity: A Novel Therapeutic Approach

Mohammad S Hossain, Ph.D, David L Jaye, MD, Brian P Pollack, MD. PhD, Alton B Farr, MD, John Roback, MD, PhD, Andrew T Gewirtz, Ph.D, Edmund K Waller, MD PhD
Journal: Blood
Blood (2011) 118 (21): 144.
https://doi.org/10.1182/blood.V118.21.144.144
Published: 2011
Journal Articles

Paradoxical Immunological Activity of Flagellin: A Novel Method to Reduce GvHD In Allogeneic HSCT Recipients.

Mohammad S Hossain, Ph.D, Andrew T Gewirtz, Ph.D, John Roback, MD, PhD, Edmund Waller
Journal: Blood
Blood (2010) 116 (21): 1465.
https://doi.org/10.1182/blood.V116.21.1465.1465
Published: 2010
Journal Articles

Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD.

Mohammad S Hossain, PhD, Andrew T Gewirtz, Ph.D., John D Roback, MD., Ph.D., Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3561.
https://doi.org/10.1182/blood.V114.22.3561.3561
Published: 2009
Journal Articles

Flagellin, a TLR5 Agonist, Down-Regulate CD62L on Donor T Cells and Limit GvHD in Allogeneic Hematopoietic Stem Cell Transplantation

Mohammad Hossain, PhD, Andrew T Gewirtz, Ph.D., John D Roback, MD., Ph.D., Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3521.
https://doi.org/10.1182/blood.V112.11.3521.3521
Published: 2008